Human herpesvirus 6A (HHV-6A) strain U1102 was previously shown to contain a 1473 bp transformation suppressor gene (ts) (Araujo et al., 1995) . Ts inhibited transformation of NIH3T3 cells by H-ras and transcription of the H-ras and human immunode®ciency type 1 (HIV-1) promoters in transient transfection experiments. In the current study, stable NIH3T3 cell lines expressing ts protein were established by transfection with pRc-ts containing the ts gene under the control of the Rous sarcoma virus (RSV) long terminal repeat (LTR) and a neomycin selectable marker. Selected cell lines contained approximately one to two copies per cell of intact ts sequences, expressed ts protein and grew at approximately the same rate as parental NIH3T3 cells. These cell lines were protected from H-ras transformation while parental and NIH3T3 cells containing the ts gene cloned in the antisense orientation were not. Expression of the chloramphenicol acetyl transferase (CAT) gene under the control of the EJ-H-ras promoter was also suppressed in the ts cell lines but not when the CAT gene was under the control of the murine osteosarcoma virus LTR or human cytomegalovirus immediate early promoter. When NIH3T3 cell lines expressing ts protein were established by infection with the retrovirus, LNCts, the cells expressed ts protein and were protected from H-ras transformation. Furthermore, bovine papillomavirus type 1 (BPV-1) transformation was also suppressed in cells cotransfected with BPV-1 plus ts and in ts expressing cell lines transfected with BPV-1. The BPV-1 p89 and p2443 promoters were down-regulated in 3T3-ts lines. Because the human papillomavirus type 16 (HPV-16) p97 promoter has similarity to the BPV-1 p89 promoter, the ability of ts to suppress p97 was also tested. Like the Hras and BPV-1 promoters, HPV-16 p97 was downregulated in 3T3-ts lines. The data indicate the utility of ts against H-ras, BPV-1 and HPV-16 promoters and their respective oncogenes.
Introduction
Human herpesvirus 6A (HHV-6A) strain U1102 was reported to contain a homologue of the adenoassociated virus type 2 (AAV-2) Rep68/78 gene with 24% identity and 51% similarity at the amino acid level (Thomson et al., 1991; Araujo et al., 1995) . Functional studies by our laboratory demonstrated that the AAV-2 Rep68/78 homologue in HHV-6A, designated ts, suppressed H-ras transformation by inhibiting the Hras promoter (Araujo et al., 1995) . Furthermore, HHV-6A ts suppressed transcription from the human immunode®ciency virus type 1 (HIV-1) long terminal repeat (LTR) promoter. Studies of HIV-1 LTR mutants demonstrated that neither Sp1 binding sites or other upstream transcriptional regulatory elements were required for ts suppression, but the`Bulge' sequence within the TAR region was critical.
While, Rep68/78 has been shown to suppress both H-ras and bovine papillomavirus type 1 (BPV-1) transformation (Hermonat, 1989 (Hermonat, , 1991 , no studies have been reported on the establishment of rodent cell lines expressing ts or Rep68/78 protein(s) and/or their challenge with H-ras or BPV-1 oncogenes.
The focus of the current investigation was to test the delivery of ts by plasmid mediated transfection and retroviral infection. Cell lines expressing ts protein grew normally and were refractory to transformation by H-ras and BPV-1 oncogenes. Moreover, transcription by the endogenous H-ras, BPV-1 p89 and p2442 and HPV-16 p97 promoters were also suppressed. Speci®city was demonstrated because neither the murine osteosarcoma virus (MSV) LTR nor the human cytomegalovirus (HCMV) immediate early promoter was suppressed by ts.
Results

Expression of ts in NIH3T3 selected cell lines
NIH3T3 cells were stably transfected with pRc-ts containing the ts gene under control of the Rous sarcoma virus (RSV) long terminal repeat (LTR). Five independent 3T3-ts stable cell lines were selected by Geneticin. Negative control 3T3-pRc and 3T3-ts(A) cell lines were established in a similar manner after transfection with pRc-RSV, the parental vector and pRc-ts(A) with ts cloned in the antisense orientation, respectively. Southern blot analysis was performed to examine the retention and state of ts DNA in the selected cell lines. After digestion with HindIII, which released the 1.8 kbp ts fragment from pRC-RSV vector sequences, one to two copies per cell of intact ts DNA were observed in each of the 3T3-ts cell lines ( Figure 1a , lanes 3 ± 7) and in the 3T3-ts-1(A) line (data not shown). To determine if the selected cell lines also expressed ts protein, Western blot analysis was performed using Ab-679, a polyclonal antibody raised against a synthetic peptide of amino acids 135 ± 153 from ts. The ability of Ab-679 to detect ts protein was con®rmed by Western blot analysis of in vitro transcribed/translated ts protein. ts protein (56 kDa) was observed after transcription/translation of pET14b-ts ( Figure 1b , lane 2) while no similar protein was seen for the pET14b vector plasmid (lane 1). With extracts of all 5 3T3-ts lines, Ab-679 detected a 56 kDa protein (lanes 3 ± 7) which was not seen in extracts of control parental NIH3T3 cells (lane 8) or in 3T3-ts-1(A) cells (data not shown). Thus, the 3T3-ts cell lines all produced ts protein.
Growth rates were measured for the 3T3-ts cell lines (Figure 1c ) to determine if expression of ts protein aected cellular growth. Lines 3T3-ts-1, 2, 4 and 5 had a doubling time between 24 and 30 h that was similar to that of NIH3T3 cells; 3T3-ts-3 grew at a slightly lower rate. However the cells appeared morphologically normal. Thus, expression of ts protein did not aect NIH3T3 cell growth.
Suppression of H-ras transformation in 3T3-ts cell lines
To determine the eect of ts expression on H-ras transformation of NIH3T3 cells, the ability of 3T3-ts, 3T3-ts-1(A), or NIH3T3 cells to be transformed by pEJ-H-ras or pMSVLTRras was compared. After transfection with pEJ-H-ras, the 3T3-ts lines exhibited less than 2% of transformed foci as compared to 3T3-ts-1(A) or NIH3T3 cells (Figure 2a ). However, all seven cell lines exhibited a similar number of transformed foci after transfection with pMSVLTRras ( Figure 2b ) indicating that the ts gene suppressed the endogenous H-ras promoter but not the MSV LTR. To con®rm that the ts eect on transformation occurred at the level H-ras expression, these lines were transiently transfected with a plasmid containing the chloramphenicol acetyl transferase (CAT) gene expressed by either the endogenous H-ras promoter (prasCAT1) or the MSV LTR (pMSVLTR-CAT). 3T3-ts-1 (Figure 2c ) and 3T3-ts-2, -3, -4 and -5 (data not shown) cells exhibited about 50% reduced CAT activity after transfection with prasCAT1 relative to NIH3T3 or 3T3-ts-1(A) cells. Approximately 50% reductions in CAT activity were repeatedly observed for the 3T3-ts cells in other experiments in which the levels of chloramphenicol acetylation observed for NIH3T3 cells were between 30 and 50% (data not shown). All seven lines (3T3-ts-1, NIH3T3, and 3T3-ts-1(A) shown in Figure 2c ; 3T3-ts-2, -3, -4 and -5 not shown) exhibited the same CAT activity after transfection with pMSVLTR-CAT. This demonstrated that suppression was speci®c to the H-ras promoter. DNA extracted from 3T3-ts cell lines was digested with HindIII, separated by 0.8% agarose gel electrophoresis, transferred to GeneScreen, and probed with 32 P-labeled ts HindIII fragment DNA. The position of the expected 1.8 kbp ts HindIII fragment is indicated. Lanes 1 and 2 are reconstruction studies in which NIH3T3 cell DNA is mixed with 1 and 2 genome per cell equivalents of pRc-ts DNA, respectively. (b) Western blot analysis. Protein extracts of NIH3T3 and 3T3-ts cell lines were separated by 4 ± 20% SDS ± PAGE electrophoresis and Western blotted using anti-ts rabbit polyclonal serum, Ab-679. As a positive control, in vitro transcribed and translated ts protein was produced employing pET14b-ts (ts cloned into the pET14b bacterial expression vector (Novagen)) as the template. The ts/antibody complex was detected by the`Western-Light' chemiluminescent detection system (TROPIX, Inc.) employing goat anti-rabbit IgG conjugated to alkaline phosphatase. (c) Growth curves. 5610 4 cells/dish of each line were seeded into replicate dishes. On days 2, 3, 4, 5, and 6, the cells were resuspended by trypsinization and counted in a hemocytometer Suppression of H-ras transformation in ts cell lines established by retroviral transfer ts expressing NIH3T3 cell lines were also established by retrorival infection employing LNCts followed by Geneticin selection. As a control, NIH3T3 cells were infected with the LNCX vector. Western blots analysis showed that the four 3T3-LNCts lines expressed ts protein (data not shown). After transfection by H-ras, 3T3-LNCts-1, -2, -3 and -4 cells exhibited 93 to 98% fewer transformed foci than did 3T3-LNCX-1 cells (data not shown). Thus, ts was eectively transferred by the LNCX retroviral infection system. ts suppression of BPV-1 transformation Next, the ability of ts to suppress BPV-1 transformation was examined. When NIH3T3 cells were cotransfected with pBPV-69T (Lowy et al., 1980) plus the pts2.6 construct (containing a 2.6 kbp SacII/PpuMI fragment of HHV-6A that includes the ts gene), transformation was suppressed by up to 51% ( Figure  3a ). In contrast, three translation termination linker (TTL) mutant ts constructs had no eect on BPV-1 transformation ( Figure 3a ) indicating that ts was required for suppression. Furthermore, when pBPV-69T was transfected into three independent 3T3-ts cell lines, a 95 ± 99% reduction in the number of foci induced was observed as compared to transfection of NIH3T3 cells (Figure 3b ). Thus, the acquisition of ts protected the NIH3T3 cells from transformation by BPV-1.
To determine if ts suppression occurred at the level of BPV-1 gene expression, two BPV-1 promoters, p89 or p2443, which express mRNAs that encode the E5 gene were tested. 3T3-ts cell lines were transfected with plasmids containing the CAT gene under control of p89 (p1066) or p2443 (p805 ± 88). For the p89 construct, CAT activity was lower in the three 3T3-ts cell lines relative to NIH3T3 cells by 56 to 82% and for the p2443 construct, CAT activity was lower by 73 to 89% (Figure 4a and b) . Thus, the suppression of BPV-1 transformation by ts was due to suppression of transcription. Moreover, the speci®city of ts suppression was demonstrated because similar levels of CAT activity were observed in NIH3T3 and 3T3-ts cell lines after transfection with either pCHC6-CAT (Figure 4c ) or pMSVLTR-CAT (data not shown), where CAT was expressed from the HCMV immediate early promoter or the MSV LTR, respectively.
ts suppression of HPV-1 expression
Because the HPV-16 p97 promoter has similarity to the BPV-1 p89 promoter, the ability of ts to suppress the p97 promoter was tested. An HPV 16 p97 CAT construct (pURR16CAT) was tested for expression of CAT activity after transfection in the 3T3-ts cell lines. As in the case of the BPV-1 promoter CAT constructs, the three 3T3-ts cell lines exhibited 70 to 88% less CAT activity (Figure 4d ) than did NIH3T3 cells after transfection with pURR16CAT. Thus, ts suppressed the HPV-16 p97 promoter.
Discussion
A 490 aa ORF in HHV-6A strain U1102 exhibiting 24% identity to the AAV-2 Rep68/78 gene was reported by Thomson et al. (1991) . Co-transfection studies demonstrated that this HHV-6A Rep68/78 homologue was a transformation suppressor (ts) of H-ras and a transcriptional suppressor of both the Hras and HIV-1 LTR promoters (Araujo et al., 1995) . The 12 kbp HHV-6A HindIII fragment and its 2.6 kbp SacII/PpuMI subfragment containing ts both suppressed H-ras transformation.
In this study, pRc-ts, containing the ts gene under control of the Rous sarcoma virus (RSV) LTR and a selectable neomycin resistance marker, was stably transfected into NIH3T3 cells to determine if cells that expressed ts protein were protected against H-ras transformation. Selected cell lines retained intact ts sequences (Figure 1a) , expressed ts protein (Figure 1b) , and exhibited similar growth rates as parental cells with a doubling time between 24 and 30 h (Figure 1c) . The lower growth rate of line 3T3-ts-3 was not thought to be due to ts protein expression because the level of ts protein was similar in this line to that in the other lines that grew at the same rate as NIH3T3 cells.
Stably transfected 3T3-ts lines suppressed transformation by greater than 98% when challenged by H-ras (Figure 2a ) while no suppression was seen when the same lines were challenged by MSVLTR-ras ( Figure  2b) . Moreover, similar levels of H-ras transformation were observed after transfection of NIH3T3 and 3T3-ts-1(A) cells with either pEJ-H-ras or pMSVLTRras. This suggested that ts suppressed the endogenous H-ras promoter. Supportive CAT assay data demonstrated suppression of the H-ras promoter but not the MSVLTR promoter in 3T3-ts-1 cells relative to NIH3T3 or 3T3-ts-1(A) cells (Figure 2c) . Moreover, 3T3-ts cells were as capable of being stably or transiently transfected as NIH3T3 or 3T3-ts-1(A) cells because they exhibited similar levels of foci and CAT activity after transfection with pMSVLTR-ras and pMSVLTR-CAT, respectively (Figure 2) . Furthermore, the extent of ts suppression of H-ras transformation observed in these studies was consistently greater in 3T3-ts lines than previously observed in cotransfected cells (Araujo et al., 1995) . This may be the result of a higher proportion of selected cells in the 3T3-ts lines expressing ts protein than in co-transfected cells.
In our previous transient transfection studies, ts suppressed H-ras transformation by about *60% while it suppressed CAT activity expressed from the endogenous H-ras promoter by *80% (Araujo et al., 1995) . In the stably ts-transfected cells described in this study H-ras transformation was suppressed by over 98%, whereas H-ras promoter expression was suppressed by only *50% (Figure 2) . Although, the explanation for this dierence in stable and transient transfection is not understood, it is clear that a small reduction in H-ras expression has a profound eect on its ability to transform cells.
Retroviral vector systems serve as a highly ecient method of gene transfer into mammalian cells with a low probability for gene rearrangement (Miller and Rosman, 1989) . The data presented in this study demonstrated that a retroviral vector could serve as a gene delivery system for ts. After employing the pLNCX system (Miller and Rosman, 1989) , 3T3-LNCts lines expressed ts protein and consistently suppressed H-ras transformation by 93 ± 98% (data not shown).
ts was next tested to determine its eect on another oncogene, BPV-1 E5. In co-transfection experiments, pts2.6 suppressed BPV-1 transformation by approximately 50% (Figure 3a) . However, greater than 95% suppression of BPV-1 transformation was observed in 3T3-ts lines (Figure 3b ). CAT activity expressed from BPV-1 p89 (p1066) and p2443 (p805 ± 88) promoters, which express the E5 oncogene, was suppressed in the 3T3-ts cells (Figure 4a and b) , while CAT expressed from the HCMV immediate early promoter was not (Figure 4c ). Rep68/78 also inhibited BPV-1 transformation (Hermonat, 1989) . However, in co-transfection studies, only minimal suppression of the BPV-1 p89 and p2443 promoters by Rep68/78 was observed. Whether the greater suppression of the BPV-1 promoters by ts as compared to Rep68/78 was intrinsic to these genes or was the result of experimental dierences is not known. Furthermore, the p97 promoter of HPV-16 which controls expression of the E6 and E7 transforming genes was suppressed in 3T3-ts cells (Figure 4d ). Hermonat (1994) has demonstrated in co-transfection studies that Rep68/78 inhibited HPV-16 transformation as well as the HPV-16 promoter.
These studies were performed to test the potential for using ts against cancers with either activated H-ras or papillomavirus. NIH3T3 cells are much more sensitive to transformation by the agents than are normal human or rodent cells. However, quantitative transformation assays can be performed only with sensitive rodent cell lines. Thus, the protection of NIH3T3 cells by stable transfer of ts from malignant transformation was the strategy for establishing the utility of ts-based therapy.
Pellett and colleagues (personal communication) have identi®ed a Rep68/78 homologue in HHV-6B strain Z-29 with greater than 96% nucleotide and amino acid identities to HHV-6A strain U1102 ts. The dierent amino acids in the two ts sequences were either similar or functionally analogous. Low levels of HHV-6B ts mRNA and protein were observed at 36 h post-infection demonstrating ts expression during HHV-6 replication.
Our previous studies have demonstrated that the ts gene suppressed CAT expression from the wild-type and ®ve dierent upstream mutant HIV-1 LTR promoters in the human CD4 + T-cell line, 12D7 (Araujo et al., 1995) . On the other hand, Thomson et al. (1994) observed that the HHV-6A rep gene homologue (i.e. ts) transactivated an HIV-1 LTR CAT construct in both Vero (African green monkey kidney) and 1BR (human skin ®broblast) cells and had no eect in the human CD4 + T-cell line, J Jahn, in contrast to AAV-2 Rep68/78 which suppressed expression in all three cell lines. The dierences between the studies of Thomson et al. (1994) and ours (Araujo et al., 1995) could be due to the cell types, promoters used for the ts and rep gene homologue expression, electroporation conditions and the levels of DNA transfected.
HHV-6A ts and AAV-2 Rep68/78 suppress transcription of the same promoters, i.e. H-ras and HIV-1, but not MSVLTR (Araujo et al., 1995; Hermonat, 1991; Antoni et al., 1991; Rittner et al., 1992; Oelze et al., 1994; Thomson et al., 1994) . Therefore, they both may interact with the same target(s). The Rep68/78 target sequence for replication in AAV-2 DNA has been identi®ed by binding and DNase footprinting studies as (GCTC) 3 (Chiorini et al., 1994) . Both the Hras promoter and the HIV-1 TAR regions contain sequences related to (GCTC) 3 (Oelze et al., 1994; Batchu et al., 1994) . The GCTC motifs within the TAR region are adjacent to the`Bulge' and`Loop' mutations that abrogated ts suppression. Moreover, the Rep78 protein was shown to bind to TAR DNA sequences (Batchu and Hermonat, 1995) . While Rep78 protein binding to the GCTC cluster in the H-ras promoter has been demonstrated (Batchu et al., 1994) , no mutation studies of this region showing loss of Rep68/78 (or ts) suppression have been reported. A search of the BPV-1 and HPV-16 sequences cloned into the CAT reporter constructs used in the ts suppression studies shown in Figure 4 revealed four GCTC (or its complement, GAGC) motifs in p1066 (BPV-1 p89), 24 in p805 ± 88 (BPV-1 p2443), and none in pURR16CAT (HPV-16 p97). Moreover, none of the GCTC motifs were found in the BPV-1 sequence in clusters. Thus, the GCTC motif was not the only critical element required for ts suppression of the promoters discussed above.
ts protein could bind to other nucleic acid sequences, proteins, or both. With regards to the HIV-1 promoter, mutation studies have indicated that the TAR region, particularly the`Bulge', was critical (Araujo et al., 1995) . Because TAR is downstream of the mRNA start site, ts binding to RNA or DNA could be involved.
Additionally, ts binding to cellular transcription factor(s) might inhibit their role in transcription. Both the HIV-1 tat protein and cellular nuclear proteins including TRP185 (Wu et al., 1991) , 44 kDa TRBP (Gatignol et al., 1991) and a 140 kDa protein (Rounseville and Kumar, 1992) can bind to TAR. In the case of the H-ras promoter, the cluster of GCTC motifs that binds Rep68 protein (Batchu et al., 1994 ) is upstream of any of the approximately 30 mRNA start sites or transcription factor binding sites that have been reported (Lu et al., 1994) . As for the papillomavirus promoters, identi®cation of critical regions for ts suppression must be determined by mutational analysis.
In summary, protection of NIH3T3 cells from H-ras transformation has been accomplished by delivering the HHV-6A ts in either of three ways, i.e. cotransfection, stable transfection and retroviral insertion. In contrast to co-transfection, both stable transfection and retroviral insertion were more eective in suppressing transformation frequency.
Materials and methods
Plasmids
The pRc-ts and pRc-ts(A) constructs contain the ts gene cloned into pRc-RSV (Invitrogen) under the control of the RSV promoter in the sense and antisense orientations, respectively, as described (Araujo et al., 1995) . pts2.6, pts2.6/TTL-25, pts2.6/TTL-125 and pts2.6/TTL-245 have been described (Araujo et al., 1995) . pET14b-ts was constructed by cloning a 1509 bp PCR ampli®ed product, synthesized with GGGAGGCGCAAACCATATG and AAGGATCCGTGGTCTTTTAAGATGT primers, into the NdeI and BamHI sites of the bacterial expression vector, pET14b (Novagen). pLNCts was constructed by subcloning the HindIII fragment containing ts from pRc-ts into the HindIII site of the retroviral vector, pLNCX (Miller and Rosman, 1989) . pEJ-H-ras contained the activated H-ras gene isolated from the EJ human bladder carcinoma cell line (Santos et al., 1982) . pMSVLTR-ras contained the activated H-ras gene under the control of the murine osteosarcoma virus (MSV) long terminal repeat (LTR) (Hermonat, 1991) . pMSVLTR-CAT and prasCAT1 contained the CAT gene expressed by the MSV LTR (Hermonat, 1991) or the endogenous ras promoter (Ishii et al., 1985) , respectively. pCHC6-CAT, containing CAT expressed by the HCMV immediate early promoter, was provided by Dr Francis Kern. pBPV-69T contains the 69% transforming region of BPV-1 (Lowy et al., 1980) . The BPV-1 promoter CAT constructs, p1066 (Spalholz et al., 1987) and p805 ± 88 (Spalholz et al., 1991) , contain the p89 and p2443 promoters, respectively. pURR16CAT contains the CAT gene under the control of the HPV-16 p97 promoter. To construct pURR16CAT, the initiating ATG of the E6 gene was mutated by PCR to AGTG, creating a PstI site. The PstI fragment containing bp 7004-103 of HPV-16 was cloned into the PstI site of pBLCAT3 (Luckow and Schutz, 1987) .
Cells, transfections and transformation
NIH3T3 cells were maintained as a subcon¯uent monolayer in Dulbecco's modi®ed Eagle's medium (Mediatech) supplemented with 7% calf serum (Hyclone), penicillin (100 U/ml), and streptomycin (100 mg/ml). Transient transfections were performed by the calcium phosphate method as described (Chen and Okayama, 1987) . To establish stably transfected cell lines, four mg pRc/RSV, pRc-ts, or pRc-ts(A) (ts cloned in the antisense orientation) were linearized within the ampicillin resistance gene with ScaI and transfected using Lipofectamine (Gibco BRL) into 2610 5 NIH3T3 cells in a 60 mm dish according to the manufacturer's protocol. After 48 h, transfected cells were subcultured into 10 cm dishes and selected with 500 mg/ml Geneticin 24 h later. Independent selected 3T3-pRc, 3T3-ts and 3T3-ts-(A) colonies were isolated and maintained in culture media supplemented with 200 mg/ml Geneticin.
pLNCX (Miller and Rosman, 1989) , is a retroviral vector carrying the HCMV`immediate early' promoter for expression in mammalian cells and a neomycin resistance marker. pLNCX and pLNCts were transfected into GP+E 86 ecotropic packaging cells. Supernatants, containing LNCX, LNCts and LNCtsTTL 125 retrovirus, were harvested 2 days post-transfection and used to infect PA137 amphotropic packaging cells. Clonal producer populations were selected by Geneticin; the titer of each of 50 producer clones for each retrovirus was assayed by determining the frequency of Geneticin resistance of infected NIH3T3 cells. The three highest titer producer clones (410 6 infectious particles/ml) for each retrovirus were selected for further use. Furthermore, four 3T3-NLCts and one 3T3-LNCX independently derived colonies were isolated to develop into cell lines.
For transformation studies (Schiller et al., 1984) , 5610 4 cells were seeded into a 35 mm dish and transfected with 3 mg of pEJ-H-ras, pMSVLTRras, or 1 mg of pBPV-69T DNA. Four independent dishes were transfected overnight for each plasmid. Cells from each dish were subcultured into a 10 cm dish at 48 h post-transfection. After 12 days, the dishes were stained with 5% Giemsa and the observed foci were counted. For co-transfection studies, cells were transfected with 1 mg of pBPV-69T plus indicated amounts of pts2.6 or pts2.6/TTL constructs. When necessary, the total amount of plasmid DNA was adjusted to 5 mg with pBLUESCRIPT (Stratagene) DNA. To determine growth rates, 5610 4 cells/dish of each line to be tested were seeded into replicate 10 cm dishes. On succeeding days, cells were resuspended by trypsinization and mixed with an equal volume of trypan blue. Cells excluding trypan blue were counted in a hemacytometer.
Southern blot analysis
Genomic DNA was isolated from cell lines by extraction with sodium dodecyl sulfate (SDS) and proteinase K (Doniger et al., 1987) . DNA was digested with HindIII, separated by 0.8% agarose gel electrophoresis and transferred to a GeneScreen nylon membrane (Dupont) by capillary action (Southern, 1975) . Hybridization was carried out overnight at 428C with 32 P-labeled ts DNA (5610 6 c.p.m/ml) in 56SSPE (0.75 M NaCl, 0.05 M sodium phosphate and 5 mM EDTA), 10% dextran sulfate, 50% formamide, 56Denhardt's solution (0.1% w/v each of Ficoll, polyvinylpyrrolidone and BSA), 1% SDS and 100 mg/ml tRNA. The ®lter was washed twice in 26SSC (300 mM NaCl, 30 mM sodium citrate), 0.1% SDS for 20 min at room temperature, once in 0.16SSC with 0.1% SDS for 20 min at 428C, once in 0.16SSC with 0.1% SDS for 20 min at 488C and exposed to Kodak XAR-2 ®lm (Eastman Kodak, Rochester NY) with intensifying screens at 7708C.
Western blot analysis
Polyclonal rabbit antibody, Ab-679, provided by Chemicon International was raised against the oligopeptide, DGNAP-KIDDWCTYAKTKKN, corresponding to amino acids 135 to 153 of the ts protein. The peptide was produced on an Applied Biosystems peptide synthesizer. In vitro transcription and translation reactions were performed according to manufacturers protocol (Promega) for 2 h at 308C using either pET14b DNA as a negative control or pET14b-ts. Protein extracts from mid-log phase mammalian cells were prepared as described (Seed and Sheen, 1988) . Protein was separated by 4 ± 20% SDS ± PAGE, transferred to the PVDF Immobilon-P membrane (Millipore), Western blotted with Ab-679, anti-ts serum (1 : 5000), and detected with the`Western-Light' chemiluminescent detection system (TROPIX) employing goat anti-rabbit IgG conjugated to alkaline phosphatase.
CAT assay
NIH3T3 or ts expressing cells were transfected with the reporter CAT plasmid prasCAT1 (20 mg), pMSVLTR-CAT (20 mg), pCHC6-CAT (5 mg), p1066 (20 mg), p805 ± 88 (20 mg), or pURR16CAT (20 mg). After 48 h extracts were prepared and the protein levels were determined. Extracts, 10 mg for prasCAT1, pMSVLTR-CAT and pCHC6-CAT, or 20 mg for p1066, p805 ± 88 and pURR16CAT were incubated in 52 ml reaction mixtures in 0.25 M Tris (pH 7.75) with 0.05 mCi of 14 C-labeled chloramphenicol and 0.02 mM acetyl coenzyme A for 3 h at 378C. Acetylated chloramphenicol species were separated by thin layer chromatography. After autoradiography, spots were cut out and counted, and the percent acetylated chloramphenicol was calculated.
